Dania Birte REICHE,Nicole MOHREN,Laura JOHNSTON,Bruce SOMERVILLE,Rebecca K. VOTH
申请号：
US16844522
公开号：
US20200237794A1
申请日:
2020.04.09
申请国别(地区):
US
年份:
2020
代理人:
摘要：
One or more SGLT2 inhibitors or pharmaceutically acceptable forms thereof are provided for use in the treatment and/or prevention of a metabolic disorder of an equine animal. For example, the treatment and/or prevention can be for laminitis, vascular dysfunction, hypertension, hepatic lipidosis, atherosclerosis, hyperadrenocorticism, Pituitary Pars Intermedia Dysfunction and/or Equine Metabolic Syndrome in an equine animal.
